Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-13.57%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$10.9B
Cap. Flow %
12.9%
Top 10 Hldgs %
10.97%
Holding
4,738
New
700
Increased
1,959
Reduced
1,484
Closed
563

Sector Composition

1 Healthcare 19.41%
2 Technology 16.81%
3 Consumer Staples 11.14%
4 Consumer Discretionary 10.11%
5 Financials 8.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACGN
4151
DELISTED
Aceragen, Inc. Common Stock
ACGN
$14K ﹤0.01%
+1,855
New +$14K
NH
4152
DELISTED
NantHealth, Inc
NH
$14K ﹤0.01%
+2,300
New +$14K
UPC icon
4153
Universe Pharmaceuticals
UPC
$2.25M
$13K ﹤0.01%
6
+2
+50% +$4.33K
NLSP icon
4154
NLS Pharmaceutics
NLSP
$9.52M
$12K ﹤0.01%
500
-43
-8% -$1.03K
TRX icon
4155
TRX Gold Corp
TRX
$127M
$12K ﹤0.01%
33,300
-577,700
-95% -$208K
ARDS
4156
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$12K ﹤0.01%
+10,804
New +$12K
THMO
4157
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$11K ﹤0.01%
+853
New +$11K
EXN
4158
DELISTED
Excellon Resources Inc.
EXN
$11K ﹤0.01%
23,800
+7,300
+44% +$3.37K
QH
4159
Quhuo
QH
$5.82M
$10K ﹤0.01%
28
+8
+40% +$2.86K
THAR icon
4160
Tharimmune
THAR
$14.9M
$9K ﹤0.01%
+30
New +$9K
UNCY icon
4161
Unicycive Therapeutics
UNCY
$77.4M
$9K ﹤0.01%
+1,100
New +$9K
NYMX
4162
DELISTED
Nymox Pharmaceutical Corp
NYMX
$9K ﹤0.01%
+19,742
New +$9K
IMV
4163
DELISTED
IMV Inc. Common Shares
IMV
$9K ﹤0.01%
+1,310
New +$9K
CIH
4164
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$9K ﹤0.01%
12,700
+1,900
+18% +$1.35K
NAVB
4165
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$9K ﹤0.01%
+12,633
New +$9K
TCBP
4166
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
0
GDC icon
4167
GD Culture Group
GDC
$88.7M
$7K ﹤0.01%
+392
New +$7K
MTC icon
4168
MMTec
MTC
$24.7M
$6K ﹤0.01%
268
-1,009
-79% -$22.6K
SMFL
4169
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$6K ﹤0.01%
+3
New +$6K
PIXY
4170
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
TMBR
4171
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$5K ﹤0.01%
316
-17,109
-98% -$271K
MITO
4172
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$4K ﹤0.01%
14,769
-32,008
-68% -$8.67K
ALNA
4173
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$3K ﹤0.01%
+17,200
New +$3K
KLDO
4174
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
-86,887
Closed -$143K
FLOW
4175
DELISTED
SPX FLOW, Inc.
FLOW
-2,900
Closed -$250K